cancer

3 articles

New daily pill doubles survival rates for pancreatic cancer patients

New daily pill doubles survival rates for pancreatic cancer patients

Triple-Targeted Therapy Achieves Durable Pancreatic Tumor Regression Preclinically

Triple-Targeted Therapy Achieves Durable Pancreatic Tumor Regression Preclinically

HDHP Cancer Patients Show Worse Survival Rates, Study Links High Deductibles to Mortality

HDHP Cancer Patients Show Worse Survival Rates, Study Links High Deductibles to Mortality